SGLT2 inhibitor (unspecified)
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for SGLT2 inhibitor (unspecified), covering 2021-02-03 to 2026-02-27. Get the full timeline:
Most recent: Clinical Trial Update: CardioRenal Effects of SGLT2 Inhibition in Kidney Transplant Recipients [Phase 2]